京尼平
壳聚糖
伤口愈合
增生性瘢痕
基质金属蛋白酶
自愈水凝胶
体内
化学
生物医学工程
细胞外基质
细胞生物学
外科
医学
生物化学
高分子化学
生物技术
生物
作者
Nihui Zhang,Tao Gao,Yao Wang,Juan Liu,Junwei Zhang,Ruijuan Yao,Fang Wu
标识
DOI:10.1016/j.ijbiomac.2020.03.161
摘要
It is of great clinical significance to design wound dressing materials with combined excellent wound healing properties and superior capability to suppress hypertrophic scar formation. This study aimed to examine if and how the cationicity of chitosan would affect the hypertrophic scar-related outcomes, through preparing carboxymethyl chitosan hydrogels with different genipin concentrations (2.5%, 5%, 10% and 15%, respectively). An optimum window of chitosan cationicity (5% in our case) demonstrated potential to mitigate hypertrophic scar in wound healing by suppressing the expression of a-smooth muscle actin (a-SMA) and promoting secretion of type I matrix metalloproteinases (MMP-1). In vivo, the CMCS-5% hydrogel again showed smaller, thinner and smoother wound appearance. Moreover, the CMCS-5% sample with additional incorporation of 2% (V/V) Aloe vera gel exhibited further improved performance in scar inhibition. Overall, such findings might have important implications in chitosan-based wound dressing design for high-quality wound repair and effective scar inhibition.
科研通智能强力驱动
Strongly Powered by AbleSci AI